rational associ sulfonylurea insulin patient non-insulin-depend diabet niddm sulfonylurea treatment primari failur patient secondari failur therapi rate year hand insulin-tr niddm patient progress increas insulin requir signific improv glucos control patient combin oral agent insulin therapi use rational therapeut approach resid synergist action agent specif mechan respons glucos intoler hyperglycemia long-act insulin singl dose supper bedtim excess overnight hepat glucos product signific reduct glucos concentr ambient glucos level stimulatori effect sulfonylurea insulin secret sulfonylurea treatment portal inflow secret insulin result increas insulin level liver postprandi hepat glucos output sulfonylurea insulin action target tissu muscl overal insulin-medi glucos metabol reduct plasma glucos level toxic effect hyperglycemia beta-cel insulin-sensit tissu basi niddm patient secondari failur monotherapi combin therapi nevertheless effect combin therapi intens insulin therapi poor control 